Type 2 Diabetes

Sex hormone-binding globulin and estradiol associated with type 2 diabetes in women

Sex hormone-binding globulin and estradiol associated with type 2 diabetes in women

Women may have a higher risk of type 2 diabetes with low levels of sex hormone-binding globulin and high levels of total estradiol.

Early intensification of diabetes therapy after metformin failure is beneficial

Early intensification of diabetes therapy after metformin failure is beneficial

By

Intensification of therapy within 6 months of metformin monotherapy failure resulted in rapid attainment of A1c goals.

Oily fish consumption may lower diabetic retinopathy risk in type 2 diabetes

Oily fish consumption may lower diabetic retinopathy risk in type 2 diabetes

By

A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.

Drug may slow renal disease progression in type 2 diabetes

Drug may slow renal disease progression in type 2 diabetes

By

Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.

Adlyxin approved for type 2 diabetes

Adlyxin approved for type 2 diabetes

The once-daily injection works to improve glycemic control.

Cultural considerations in diabetes: controlling HbA1c in a patient observing Ramadan

Cultural considerations in diabetes: controlling HbA1c in a patient observing Ramadan

By

A patient with type 2 diabetes is undergoing dialysis and needs to control his HbA1c levels while fasting during Ramadan.

New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity

New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity

By

A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.

Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients

Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients

By

Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.

FDA issues warning for 2 diabetes drugs linked to risk of heart failure

FDA issues warning for 2 diabetes drugs linked to risk of heart failure

By

The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.

Managing nephropathy in a patient with type 2 diabetes

Managing nephropathy in a patient with type 2 diabetes

By

A patient with type 2 diabetes presents with elevated microalbumin levels and a recent history of elevated glucose due to bedtime snacking.

Body fat percentage, physical fitness are better predictors of mortality and diabetes risk than BMI

Body fat percentage, physical fitness are better predictors of mortality and diabetes risk than BMI

By

High body weight percentage may increase mortality, and poor physical fitness in youth can increase diabetes risk later in life.

CPAP leads to improved glycemic control in patients with type 2 diabetes

CPAP leads to improved glycemic control in patients with type 2 diabetes

The CPAP group had a larger decrease in HbA1c levels after 6 months.

Managing diabetes in primary care: 2016 recommendations from ADA

Managing diabetes in primary care: 2016 recommendations from ADA

By

The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.

Once-weekly GLP-1RAs beneficial for type 2 diabetes

Once-weekly GLP-1RAs beneficial for type 2 diabetes

By

Once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose.

Is heart failure linked to DPP-4 inhibitor use in patients with diabetes?

Is heart failure linked to DPP-4 inhibitor use in patients with diabetes?

By

Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.

Statin plus niacin reduces apoB-48 concentration in type 2 diabetes

Statin plus niacin reduces apoB-48 concentration in type 2 diabetes

A statin plus extended-release niacin reduces apoB-48 concentrations in patients with type 2 diabetes, compared with a statin alone.

Patients with type 2 diabetes may undergo unnecessary HbA1c testing

Patients with type 2 diabetes may undergo unnecessary HbA1c testing

More than 60% of the 31,545 patients analyzed between 2001 and 2013 underwent HbA1c at least four times per year.

Breastfeeding may reduce odds of developing type 2 diabetes

Breastfeeding may reduce odds of developing type 2 diabetes

Breastfeeding for 2 or more months may reduce the odds of developing type 2 diabetes in mothers previously diagnosed with gestational diabetes.

Severe insulin resistance in a patient with type 2 diabetes

Severe insulin resistance in a patient with type 2 diabetes

Patients with type 2 diabetes and severe insulin resistance may require large doses of insulin to achieve glycemic control.

Renal biomarkers predict adverse outcomes in diabetes

Renal biomarkers predict adverse outcomes in diabetes

Three renal biomarkers - AKI, albuminuria, and eGFR - can predict adverse outcomes in diabetes, according to a study published in Diabetes Care.

Smoking is associated with
 high risk of type 2 diabetes

Smoking is associated with
 high risk of type 2 diabetes

By

A meta-analysis of 88 studies show a concrete link between current smokers and an elevated risk of type 2 diabetes.

USPSTF recommends new screening guidelines for type 2 diabetes

USPSTF recommends new screening guidelines for type 2 diabetes

By

Clinicians should screen all asymptomatic, obese adults for abnormal blood glucose levels, says the U.S. Preventative Services Task Force.

Long naps, daytime sleepiness may increase type 2 diabetes risk

Long naps, daytime sleepiness may increase type 2 diabetes risk

Daytime sleepiness and long naps may be associated with significantly increased risks of developing type 2 diabetes.

Half of U.S. adults have type 2 diabetes or prediabetes

Half of U.S. adults have type 2 diabetes or prediabetes

Almost half of adults in the United States have either type 2 diabetes or prediabetes, though many are undiagnosed.

SGLT2 receptor blockers 
for diabetes


SGLT2 receptor blockers 
for diabetes


SGLT2 receptor blockers are only approved for type 2 diabetes.

Combination drug for adults with type 2 diabetes mellitus

Combination drug for adults with type 2 diabetes mellitus

Glyxambi is adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.

DPP-4 inhibitors may cause severe joint pain in type 2 diabetes

DPP-4 inhibitors may cause severe joint pain in type 2 diabetes

The FDA released a warning that DPP-4 inhibitors may lead to severe joint pain in patients with T2DM.

Diabetes insulin type does not affect myocardial infarction risk

Diabetes insulin type does not affect myocardial infarction risk

Using long-acting insulin in type 2 diabetes does not increase the risk for acute myocardial infarction.

Eating breakfast helps control glucose in type 2 diabetes

Eating breakfast helps control glucose in type 2 diabetes

People with type 2 diabetes who skipped breakfast had a higher risk of postprandial hyperglycemia.

Eating carbs last in a meal lowers glucose levels

Eating carbs last in a meal lowers glucose levels

Eating carbohydrates last helped lower glucose levels, especially if vegetables and proteins were eaten first.

Sign Up for Free e-newsletters